Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-017449

Chief Executive Officer bought 8,600 shares at $0.37 ($3,182)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-09 Purchase : show line 1 in the form +8,600 $0.37 $3,182 83,930 D
Open-market purchases · 8,600 sh · avg $0.37 · $3,182
Loading xslF345X03/doc4.xml…